Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00607659 · ClinicalTrials.gov registry record
Immunopathogenesis of Chlamydia
A clinical trial of Chlamydia Infections, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- 29
- Enrollment target
- 1
- Study location
NCT00607659 is a study of Chlamydia Infections that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 29 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00607659, a study of Chlamydia Infections, has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
Sexually transmitted Chlamydia trachomatis infections are a widespread public health concern due to their prevalence and potentially devastating reproductive consequences, including pelvic inflammatory disease, infertility, and ectopic pregnancy. The goal of this study is to evaluate the risk factors for adverse outcomes following genital tract infection with Chlamydia trachomatis and to evaluate whether or not the presence of C. trachomatis in the rectum act as a reservoir for infection.
Conditions Studied
Interventions
- OTHER No intervention, only observational
Study Locations (1)
Arkansas
- Arkansas Children's Hospital - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2008-01 |
| Est. Completion | 2016-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00607659
The ClinicalTrials.gov registry entry for NCT00607659 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chlamydia Infections appearing as the primary indexed condition, and to 1 intervention - of which No intervention, only observational is the first listed.
NCT00607659 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT00607659 about?
NCT00607659 is a clinical study titled "Immunopathogenesis of Chlamydia". Sexually transmitted Chlamydia trachomatis infections are a widespread public health concern due to their prevalence and potentially devastating reproductive consequences, including pelvic inflammatory disease, infertility, and ectopic pregnancy. The goal of this study is to evaluate the risk factor...
What is the current status of trial NCT00607659?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2008-01. Estimated completion is 2016-01.
What conditions does trial NCT00607659 study?
This clinical trial studies the following conditions: Chlamydia Infections.
What interventions are being tested in trial NCT00607659?
The interventions under investigation include: No intervention, only observational (OTHER).
Who is sponsoring clinical trial NCT00607659?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00607659 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chlamydia Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.